The use of hematopoietic stem cells for in utero transplantation to create permanent hematochimerism represents a new concept in fetal therapy, although this approach has provided heterogeneous results. In this paper we have undertaken molecular, phenotypic and functional studies aimed at identifying the presence of fully competent T lymphocytes in samples of fetal livers and cord blood. We found mature VDJ TCR ␤ chain transcripts in fetal liver cells taken from 7 to 16 weeks of gestation and a similar pattern was detected in cord blood cells sampled from 13.5 to 20.5 weeks of gestation. A V␤8 gene sequence comparable to that detected in adult PBMC was found in fetal liver samples at 9 or 17 weeks gestation. PreT␣ message was detected in all samples and its expression decreased in fetal blood samples with increasing gestational age while C␣ message appeared at 9.4 weeks and its expression increased during gestational age. T cell clones obtained from fetal liver cells showed a mature TCR ␣␤ + , CD8 + phenotype and displayed strong alloreactivity against allo-MHC class I molecules. The presence of alloreactive T lymphocytes may explain the failure to engraft in fetuses older than 13 to 16 weeks and may provide insights into fetal liver transplantation. Bone Marrow Transplantation (2000) 25, 135-141. Keywords: cytokines; mRNA; T cell receptors The use of fetal hematopoietic stem cells (HSC) for in utero transplantation to create permanent hematochimerism represents a new concept in fetal therapy.
The use of fetal hematopoietic stem cells (HSC) for in utero transplantation to create permanent hematochimerism represents a new concept in fetal therapy. 1 In utero allogeneic fetal liver cell transplantation for hereditary diseases has provided quite heterogeneous results and successful engraftment of fetal liver HSC has been shown to depend on several parameters. These include the mode of administration of fetal liver cells, the concentration of donor cells and the donor's and recipient's gestational maturity. [2] [3] [4] [5] In our experience, failure of engraftment has occurred when donor liver cells obtained from fetuses before the 12th week of gestation have been transplanted into fetuses at the 13th to 18th week of gestation. [6] [7] [8] Considerably better results have been obtained in fetuses affected by immunodeficiency syndromes such as SCID or Bare Lymphocyte diseases. 1, 9 These findings raise the possibility that the fetus may develop an allogeneic immune reaction responsible for graft failure. Accordingly, fetal liver HSC were capable of engraftment in syngeneic, but not allogeneic recipient mice, 10 and successful allogeneic in utero transplantation of fetal HSC in sheep and monkeys occurred if both the donor and recipient fetuses were in a preimmune status. 5 Furthermore, we have recently reported 7 that in utero transplantation of an 18 week fetus with fetal HSC resulted in graft failure and after birth the recipient had a very high cytotoxic T cell precursor (CTLp) frequency against donor cells, thus indicating that generation of an alloimmune response rather than tolerance induction was the effect of the procedure.
The development of T lymphocytes starts primarily in the embryonic thymus [11] [12] [13] after 8 weeks gestation, where they undergo a complex series of differentiation events leading to the expression of the T cell receptor (TCR) complex.
14 Efficient performance of this program appears to be dependent on cellular interactions between developing thymocytes and thymic stromal components. 15 These cells may then colonize the periphery, including the fetal liver itself, as the presence of phenotypically mature T cells has been demonstrated in 11-13 to 22 week old fetal livers. 16 Moreover, recent studies have shown that the liver is also a site for extrathymic T cell development and maturation. 17 Against this background, we have undertaken molecular, phenotypic and functional studies aimed at identifying the presence of fully competent T lymphocytes in samples of fetal livers and cord blood, with particular regard to their alloreactive properties.
Materials and methods

Cell samples
Human fetal livers were sampled from a tissue bank for fetal stem cell transplantation, as a pool of cryopreserved fetal liver cells from two to five donors taken at the same week of gestation. 6, 18 Fetal livers were obtained from legal abortions perfor-med with vacuum curettage at gestational weeks 5-11. After passage through a metal mesh, the cells were suspended in RPMI 1640 medium, 10% AB serum and 10% DMSO and stepwise frozen over 24 h to −190°C. The individuals who had given their consent and donated fetal tissue were serologically screened for HIV-1, syphilis, toxoplasmosis, cytomegalovirus, hepatitis B and C, parvovirus and herpes simplex virus. Sex and AB0 type were determined for selection of donors. Frozen fetal liver cells stored for 3 months were thawed in a water bath at 37°C, diluted in RPMI with 10% AB serum and washed three times. Viability was evaluated with trypan blue and was more than 85%. 8 Cord blood was obtained by cordocentesis for prenatal diagnosis of hemoglobinopathies. 19 The site of sampling was the placental cord insertion. A 25G × 90 mm spinal needle was used. The operator held both the probe (Toshiba Sonolayer VSSA 90A, 3-75 MHz sector phased array; Toshiba, New York, NY, USA) and the needle, while the assistant aspirated the blood. Fetal blood was aspirated without local anaesthesia or maternal sedation and under sterile conditions. The purity of the sample was confirmed in all cases by a Coulter Counter ZF (Coulter Electronics, Luton, UK). Fetal samples were from 6 to 20.5 weeks gestation, with the gestational age determined by crown/rump length, foot length and menstrual records. Cell suspensions were obtained from liver samples, and mononuclear cells were separated by centrifugation over Ficoll-Hypaque (Pharmacia Upjohn, Uppsala, Sweden), through which mature red blood cells and hepatocytes sedimented. The cells at the interface were then washed three times in RPMI 1640 (Gibco, Paisley, UK) containing 2 mm lglutamine, 10 mm Hepes, 100 U/ml penicillin, 100 mg/ml streptomycin and 10% heat-inactivated pooled human AB serum.
Generation of T cell clones from fetal liver cultures
Freshly isolated fetal liver mononuclear cells were cultured in 96-well round-bottomed microtiter plates (Costar, Cambridge, MA, USA) at 3 × 10 4 cells/well in complete medium containing rIL-2 (200 U/ml, final concentration) (Hoffman-La Roche, Basel, Switzerland), PHA (Leucoagglutinin; Sigma, Milan, Italy, 1 g/ml final concentration) and irradiated (3000 cGy from a Caesium source) fresh allogeneic peripheral blood mononuclear cells (1.5 × 10 5 /well). This procedure was repeated after 2 weeks. Cells were analyzed both phenotypically and functionally 4 weeks after initial stimulation.
Clones were generated from these T cell lines by limiting dilution using 0.3 cells/well, PHA, rIL-2 and irradiated allogeneic peripheral blood mononuclear cells, as described above.
Proliferation assay
Fetal liver T cell lines or clones (5 × 10 4 /well) were cultured for 3 days at 37°C in 5% CO 2 in 96 well flat-bottom plates (Nunc, Copenhagen, Denmark) in the presence of the following stimuli, at the indicated final concentrations: PHA (1 g/ml), immobilized anti-CD3 mAb (10 g/ml, OKT3, dissolved in Tris 0.05 m-1% BSA and incubated overnight at 4°C in each well of test plates), immobilized anti-TCR mAb (10 g/ml), irradiated allogeneic peripheral blood mononuclear cells (2 × 10 5 /well). In some experiments, the proliferation assay was performed in the presence of anti-CD4 (RPA-T4; Pharmingen, San Diego, CA, USA), anti-CD8 (RPA-T8; Pharmingen), anti-MHC class I (G46-2.6), anti-MHC class II (TU39; Pharmingen) and isotype-matched control mAbs as controls added at the beginning of the culture at a final concentration of 10 g/ml. At day 3, 1 Ci/well of methyl-3 H-thymidine (Amersham, Bucks, UK) was added to each well and radioactivity was measured in a liquid scintillation ␤-counter. 
Flow cytometry analysis
Cells were incubated with saturating amounts of the corresponding mAbs at 4°C for 30 min, followed by two washes. FITC-conjugated F(ab′) 2 goat anti-mouse IgG (Southern Biotechnology Associates, Birmingham, AL, USA) was used as a second-step reagent. Irrelevant isotype-matched mAbs (Becton Dickinson) were used as negative controls. Quantitation of the surface staining of 10 5 viable cells was performed using a FACScan flow cytometer (Becton Dickinson, Mountain View, CA, USA) using forward scatter/side scatter gating to select the lymphocyte population.
PCR analysis
Total cellular RNA was isolated from fetal livers and cord blood samples by the RNAzol-B procedure (Clontech, Palo Alto, CA, USA). Reverse transcription of total RNA (1 g) into single-stranded cDNA was performed using reverse transcriptase and oligo dT primers according to the manufacturer's recommendations (Boehringer Mannheim, Freiburg, Germany). PCR amplifications were performed with 80% of each cDNA sample in 100 l reaction volume containing 2.5 U Taq polymerase and 50 pmol each of genespecific primers as previously described. 20, 21 The remaining 20% of each cDNA sample was coamplified using ␤-actinspecific primers, as described by Tanaka et al. 22 Amplification products were analyzed by electrophoresis on a 2% agarose gel with ethidium bromide staining. In some experiments, specific amplification products were subjected to one cycle of labelling by using 32 P V␤ primers (30 s at 94°C, 30 s at 60°C, 30 s at 72°C and 10 sec at 72°C) in a final volume of 50 l of PCR reaction mixture. Fifty percent of the labelled products were analyzed by electrophoresis in a 2% agarose gel, stained with ethidium bromide and autoradiographed for 4-12 h. 20, 21 To analyze preT␣ and C␣ chain expression an RT-PCR was performed by using two sets of gene-specific primers and approximately 1 g of total RNA isolated from fetal liver and fetal blood samples, already studied for TCR-V␤ family expression. 23 Each sample was also amplified for ␤-actin.
Polyclonal V␤8 sequencing
The following polyclonal sequencing of TCR-␤ variable domains was performed. After reverse transcription, cDNAs from fetal liver samples were amplified with V␤8-C␤ primers as previously described. PCR products were purified by microconcentrator CENTRICON 30 (Amicon, Beverly, MA, USA), dried and resuspended in TE. Direct sequencing was performed using the dideoxy method (USB Sequenase Version 2 kit; USB, Cleveland, OH, USA) and a specific nested primer in the V␤8 region labelled with ␥ 32 P-ATP by a polynucleotide kinase reaction according to the manufacturer. Data were digitalized with a phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA) and background was subtracted using the National Institutes of Health Image 1.52 software with the vertical 1D subtraction procedure.
Sequences of oligonucleotides used
The following oligonucleotides were synthesized in our laboratory using a synthetizer Oligo 1000 Beckman (Fullerton, CA, USA). Pre-T␣ PCR primers: PreT␣: 5′-GCA GGT CCT GGC TGT AGA AGC-3′; PreT␣2: 3′-GGC ACA CCC TTT CCT TCT CTG-5′. The size of amplified products was 400 base pairs.
V␤8 sequencing primer: 5′-ATA GAT GAT TCA GGG ATG-3′. 23 Statistics Double-tailed Student's t-test was used to analyze the significance of differences between control and experimental groups.
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Results
Transcription of genes coding for ␣, preT␣ and ␤ chains of the TCR in fetal liver and cord blood cells
To analyze whether mature T lymphocytes were present in human fetal liver and cord blood cells, we studied expression of genes coding for TCR chains by RT-PCR. Aliquots of cDNAs synthesized from similar amounts of total RNA obtained from freshly isolated cells were amplified using V␤-specific primers. Equivalence of cDNAs was assessed using ␤-actin-specific primers. All primer combinations failed to amplify products from irrelevant cDNA (Daudi Burkitt's lymphoma B cells and HeLa cells) or when cDNA was omitted from the reaction.
As shown in Table 1 and Figure 1 , no TCR VDJ ␤ mature message was detected in livers sampled at 6 weeks gestation, but as early as 7.5 weeks gestation we found transcription of the V␤2 rearrangement by 32 P V␤-specific primers (data not shown). Four out of the 10 V␤ tested families (V␤ 2, 3, 4 and 7) were found transcribed at 9.2 weeks gestation with differences between liver samples only in Figure 2 ). The presence of a TCR ␤ rearrangement at 9.4 and 17 weeks was confirmed by polyclonal sequencing of the V␤8 gene product, in which a clearly legible V␤8 sequence was detected in fetal liver cells (data not shown).
PreT␣ messages were detected in all samples and its expression decreased in fetal blood samples with increasing the gestational age (Figure 3a) . C␣ messages that appeared at 9.4 weeks gestation and its expression increased during the gestational age (Figure 3b ).
Functional analysis of T lymphocytes from fetal liver
The molecular analysis demonstrating that the fetus shows a fully developed T cell receptor repertoire after 13.5 weeks gestation, prompted us to further investigate whether these rearranging T lymphocytes are mature cells from a functional point of view. To this end, short-term T cell lines were generated from freshly isolated mononuclear cells obtained from a pool of 16 week old fetal livers, by cultur- All the samples were tested for V␤ messages in RT-PCR using specific primers for V␤ and C␤. a Samples of fetal liver cells have to be considered as pools (see Materials and methods). ing them in vitro with PHA, IL-2 and allogeneic PBMC. Sixty independent T cell lines were obtained after 4 weeks in vitro culture. FACS analysis showed that they were CD3 + , TCR ␣␤ + and CD45RO + , and most of them consisted of 60-75% CD8 + and 20-25% CD4 + cells. Figure 4 shows a typical FACS panel of one of these T cell lines.
We tested the ability of these cells to respond in vitro to different stimuli. All 60 T cell lines were fully able to proliferate in response to PHA, immobilized anti-CD3 and anti-TCR ␣␤ mAbs. Three out of the 60 T cell lines also showed a proliferative response to alloantigens, ie allogeneic PBMC obtained from the same donor used to select the lines and from an irrelevant third-party donor (data not shown). To give insights into the alloreactive nature of these cells, T cell clones were generated independently from the three alloreactive T cell lines. A total of 12 T cell clones were obtained, four of which were typed as CD4 + , while eight were CD8
+ . The CD8 + T cell clones were shown to display strong alloreactivity in vitro. Figure 5 shows the pattern of proliferation of one typical clone that proliferated in response to alloantigens. This alloreactive response was inhibited by anti-CD8 mAb added to cultures and by anti-HLA class I mAb, but not by anti-class II mAb.
Discussion
The use of hematopoietic stem cells for in utero transplantation to create permanent hematochimerism represents a new concept in fetal therapy. In utero allogeneic fetal liver cell transplantation for hereditary diseases has provided quite heterogeneous results and successful engraftment of fetal liver HSC has been shown to depend on several parameters among which are the mode of administration of fetal liver cells, the concentration of donor cells, the donor and the recipient gestational maturity. [2] [3] [4] [5] This study was prompted by our observations that failure of engraftment has occurred when donor liver cells obtained from fetuses before the 12th week of gestation were transplanted into fetuses at 13th to 18th weeks gestation. [6] [7] [8] Considerably better results have been obtained in fetuses affected by immunodeficiency syndromes such as SCID or Bare Lymphocyte diseases. 1, 9 These findings raised the possibility that fetuses may develop an allogeneic immune reaction responsible for graft failure. Accordingly, fetal liver HSC were capable of engraftment in syngeneic, but not allogeneic recipient mice, 10 and successful allogeneic in utero transplantation of fetal HSC in sheep and monkeys occurred if both the donor and recipient fetuses were in a preimmune state. 5 Initial molecular analysis revealed mature VDJ TCR ␤ chain trancripts in fetal liver cells taken from 7.5 to 16 weeks gestation. The pattern of TCR ␤ transcription consistently increased with gestational age at which livers were sampled and at 16 weeks six out of the 10 tested V␤ gene families were found to be transcribed (Table 1, Figure 1) . A similar pattern was detected in cord blood cells sampled from 13.5 to 20.5 weeks after gestation. A V␤8 gene sequence comparable to that detected in adult PBMC was detected in fetal liver samples at 9 or 17 weeks gestation (data not shown).
The finding that one VDJ ␤ transcript (V␤2) was found in fetal livers sampled at 7.5 weeks is intriguing. In fact, this means that TCR ␤ rearrangement may occur in the fetal liver prior to migration of T cell precursors to the thymus. Although Sanchez and coworkers 16 showed that the expression of genes coding for the TCR ␣ and ␤ chains is a thymus-restricted T cell maturation event, both the presence of prethymic transcription of TCR genes by adult Bone Marrow Transplantation murine bone marrow cells 24, 25 and phenotypic and morphologic analysis, using anti-human mAbs, of fetal tissue at 8.2 weeks gestation 12 suggested early T cell development. The possibility that the reported results might be due to maternal T lymphocyte contamination can be excluded by the fact that fetal livers were harvested in such a way as to exclude or minimize contact with maternal blood and by determination of karyotype, blood groups and HLA class I and II antigens by PCR. 18, 26 In any event, further molecular analyses are required to fully investigate the presence of TCR ␤ transcripts before thymic development.
The most important finding we report in this paper is that the fetus shows a fully developed T cell receptor repertoire after 13.5 weeks, as documented by molecular analysis carried out on fetal liver and cord blood cells. Evidence that these rearranging T lymphocytes are mature cells was obtained on 16 week old fetal livers. As shown in Figures 4 and 5, T cell clones, obtained from these cells, showed a mature TCR ␣␤ + , CD8 + phenotype and displayed strong alloreactivity against allo-MHC class I molecules. This was detected by in vitro mAb blocking studies showing that the alloreactive response could be blocked by addition to cultures of mAbs to CD8 and HLA class I, but not class II, molecules. This means that fetal liver cells contain CD8 + T lymphocytes which are fully able to generate an alloresponse directed towards MHC class I molecules. However, the very low yield of clones from T cell lines derived from fetal livers, strongly suggests that the frequency of alloreactive T cells at that site is very low, and we have estimated it to be around 0.2/10 6 cells. Similarly low, yet significant, alloreactive response has been demonstrated within CD8 + T lymphocytes from cord blood, which has been correlated with the reduced GVHD observed after transplantation with cord blood cells. 27 The presence of alloreactive T lymphocytes, directed toward allogeneic HLA class I molecules, may provide insights into fetal liver transplantation. In fact, the presence of these cells may provide an explanation of the failure in engraftment in fetuses older than 13 to 16 weeks. At this time the fetus may be able to reject allogeneic fetal liver transplants. Accordingly, we have recently reported 17 that in utero transplantation of an 18 week fetus with fetal HSC resulted in graft failure, and after birth the recipient had a very high cytotoxic T cell precursor (CTLp) frequency against donor cells, thus indicating generation of an alloimmune response.
Overall, our results indicate that further detailed information, as well as definition of fetal T lymphocytes may be of paramount importance for planning further clinical trials in intrauterine transplantation. The results reported here may provide useful information on the stages of T cell development and can help us in devising strategies for immune reconstitution of a variety of acquired and congenital T cell immune deficiency syndromes.
